141 related articles for article (PubMed ID: 25662941)
1. Histological subtype of medulloblastoma frequently changes upon recurrence.
Pöschl J; Koch A; Schüller U
Acta Neuropathol; 2015 Mar; 129(3):459-61. PubMed ID: 25662941
[No Abstract] [Full Text] [Related]
2. Genetics of recurrent medulloblastoma.
Zollo M
Lancet Oncol; 2013 Nov; 14(12):1147-8. PubMed ID: 24140202
[No Abstract] [Full Text] [Related]
3. Neuro-oncology: Stability of medulloblastoma subgroups at tumour recurrence.
Grill J; Dufour C
Nat Rev Neurol; 2014 Jan; 10(1):5-6. PubMed ID: 24323052
[No Abstract] [Full Text] [Related]
4. Cerebellar primitive neuroectodermal tumor with multipotent differentiation in a family with von Hippel-Lindau disease. Case report.
Becker R; Bauer BL; Mennel HD; Plate KH
Clin Neuropathol; 1993; 12(2):107-11. PubMed ID: 8386599
[TBL] [Abstract][Full Text] [Related]
5. Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
Ricklefs FL; Fritzsche F; Winkler B; Meissner B; Dührsen L; Westphal M; Rutkowski S; Martens T; Schüller U
Childs Nerv Syst; 2019 Jun; 35(6):1029-1033. PubMed ID: 30796558
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in two brothers.
Yamashita Y; Handa H; Toyama M
Surg Neurol; 1975 Aug; 4(2):225-7. PubMed ID: 1162594
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
8. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
[TBL] [Abstract][Full Text] [Related]
9. Panventricular medulloblastoma.
Bhatoe HS; Dutta V; Chaturvedi A
J Neurooncol; 2005 Sep; 74(3):281-2. PubMed ID: 16187024
[No Abstract] [Full Text] [Related]
10. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
11. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
12. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
[No Abstract] [Full Text] [Related]
13. Molecular progression of SHH-activated medulloblastomas.
Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Sievers P; Meyer J; Schrimpf D; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; von Deimling A; Kool M
Acta Neuropathol; 2019 Aug; 138(2):327-330. PubMed ID: 31030238
[No Abstract] [Full Text] [Related]
14. Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.
Tamayo P; Cho YJ; Tsherniak A; Greulich H; Ambrogio L; Schouten-van Meeteren N; Zhou T; Buxton A; Kool M; Meyerson M; Pomeroy SL; Mesirov JP
J Clin Oncol; 2011 Apr; 29(11):1415-23. PubMed ID: 21357789
[TBL] [Abstract][Full Text] [Related]
15. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
16. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Kameda-Smith MM
Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.
Chargari C; Feuvret L; Levy A; Lamproglou I; Assouline A; Hemery C; Ghorbal L; Lopez S; Tep B; G GB; Lang P; Laigle-Donadey F; Cornu P; Mazeron JJ; Simon JM
Br J Neurosurg; 2010 Aug; 24(4):460-7. PubMed ID: 20726753
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of medulloblastoma 19 years after the initial diagnosis.
Amagasaki K; Yamazaki H; Koizumi H; Hashizume K; Sasaguchi N
Childs Nerv Syst; 1999 Sep; 15(9):482-5. PubMed ID: 10502011
[TBL] [Abstract][Full Text] [Related]
19. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of adult medulloblastomas: A review of the literature and perspectives].
Riffaud L; Hénaux PL
Neurochirurgie; 2016 Feb; 62(1):46-52. PubMed ID: 26657111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
